Brian Hotchkiss

Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA.

Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Jenner & Block LLC provides legal services. It focuses on mergers and acquisitions, securities, finance, private equity, real estate, tax, environmental, insurance, commercial law, technology, intellectual property, bankruptcy and reorganization, labor and employment, executive compensation, government contracts, health care and associations. The company was founded in 1914 and is headquartered in Chicago, IL.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.

Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY.

San Francisco Opera Association owns and operates opera theater. It offers an array of training programs and performance opportunities for young artists under the support of the San Francisco Opera Center and the Merola Opera Program. The company was founded by Gaetano Merola in 1923 and is headquartered in San Francisco, CA.

Morningside Group (Morningside Group) is a venture capital and private equity firm founded in 1986 by Lok Chung Chan and Chi Chung Chan. The firm is headquartered in Hong Kong.

New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY.

Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA.

Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA.

Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom.

MetaCure (USA), Inc. engages in the development and commercialization of invasive treatment for diabetes. The company was founded by Shlomo Ben-Haim in 2003 and is headquartered in Orangeburg, NY.

Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA.

MatriVAX, Inc. operates as a biotechnology company. It develops technologies for simplified, low-cost production of vaccines against polysaccharide antigens from pathogenic bacteria. The company was founded by Yichen Lu and John Mekalanos in 2007 and is headquartered in Boston, MA.

InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA.

Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA.

Part of Baxter International, Inc., Baxter Healthcare Ltd. is a company based in Newbury, UK. Baxter Healthcare Ltd. helps maximize safety, streamline processes, and build cost efficiency throughout the hospital, from the pharmacy to the bedside. The British company was founded in 1948. José E. Almeida has been the CEO of the company since 2016.

Insilixa, Inc. develops molecular diagnostic platform. It offers CMOS biochips for microarray technology, qPCR, and DNA sequencing. The company was founded by Arun Manickam and Arjang Hassibi in 2012 and is headquartered in Sunnyvale, CA.

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

CU-BX Automotive Technologies Ltd. develops remote, contact-free driving monitoring sensors technology which enables users to detect deterioration in medical conditions. It monitors remotely biometric parameters such as blood pressure, cardiographs, muscle activities, heart and lung sounds, and biochemical screens. The company was founded by Asher Polani, Evgeny Beiderman, Amit Klir, Javier Garcia, and Zeev Zalevsky on March 8, 2015 and is headquartered in Tel Aviv, Israel.

Canopy Education, Inc. engages in the operation of a mentorship, test preparation and college consulting firm. It offers college and elite application programs, college essay assistance, school list creation and subject tutoring services. The company was founded by Zack Perkins, Johan Zhang, Mohan Zhang, and Vinay Bhaskara in 2013 and is headquartered in Cambridge, MA.

Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009.

10032506 Canada, Inc. is a Canadian Montreal-based company founded in 2016 by Marc Reeves, Etienne de Villers-Sidani, and Yves Desgagné. The company has developed a patented mobile technology for capturing digital biomarkers of neurodegenerative and mental diseases such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, and related disorders, frontotemporal dementia, and related disorders, as well as cancer-related cognitive disorders ("chemo brain"). The technology is embodied in an ISO/HIPAA-compliant system consisting of an intuitive iPad Pro application connected to a cloud-based artificial intelligence infrastructure. The application consists of a series of simple visual tasks that are completed in a matter of minutes, and the users' eye movements and gaze patterns are extracted and recorded in the form of hundreds of measurements called eye movement biomarkers (EMB) and gaze mapping biomarkers (GMB). The company's mission is to become the digital leader in mobile applications that can easily extract EMBs and GMBs through its AI-powered technology to better meet the needs of the healthcare system. Etienne de Villers-Sidani has been the CEO since 2016.

Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA.

Part of Paligroup Management LLC, Arrive Enterprises LLC operates hotels. The company is based in Los Angeles, CA. The CEO of the company is Matt Steinberg. Arrive Enterprises was acquired by Paligroup Management LLC on November 30, 2020.

Natural Polymer International Corp. manufactures and markets pet products. Its services include product development, design and formulation, computer-aided design drawing, production mold and dies, temporary molds and dies, raw material sourcing, injection molding, extrusion, co-extrusion and cold-extrusion, packing, and display design. It products include N-bone, Twistix, and Get Naked. The company was founded by Scott Wang and Lok Chung Chan in 1996 and is headquartered Plano, TX.